glp-1 optimal ECL x Up Inno Shred™ GLP-1

Adults with obesity who reported more intense tastes while receiving semaglutide or tirzepatide had a higher likelihood for increased satiety and decreased appetite and food cravings, according to a presenter

This diet not only ameliorates insulin resistance and maintains a healthy body weight but also regulates immunomodulation, enhances gut microbiome diversity and provides essential phytonutrients, collectively preventing inflammation

Clinical trials show average weight loss can reach 15-20% of body weight - SURMOUNT-1 and STEP-1 trials confirmed this in thousands of patients

NAC ($15/mo) fixes it

Therapeutic Advances in Endocrinology and Metabolism, 6(1), 19-28

Developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) has been a surprisingly challenging task